Literature DB >> 26195322

Somatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen.

Joshua R Menke1, David R Raleigh, Allen M Gown, Sean Thomas, Arie Perry, Tarik Tihan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26195322     DOI： 10.1007/s00401-015-1459-3

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  24 in total

Review 1.  Diagnostic challenges in meningioma.

Authors:  Martha Nowosielski; Norbert Galldiks; Sarah Iglseder; Philipp Kickingereder; Andreas von Deimling; Martin Bendszus; Wolfgang Wick; Felix Sahm
Journal:  Neuro Oncol       Date:  2017-11-29       Impact factor: 12.300

Review 2.  PET imaging in patients with meningioma-report of the RANO/PET Group.

Authors:  Norbert Galldiks; Nathalie L Albert; Michael Sommerauer; Anca L Grosu; Ute Ganswindt; Ian Law; Matthias Preusser; Emilie Le Rhun; Michael A Vogelbaum; Gelareh Zadeh; Frédéric Dhermain; Michael Weller; Karl-Josef Langen; Jörg C Tonn
Journal:  Neuro Oncol       Date:  2017-11-29       Impact factor: 12.300

Review 3.  Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Nasal Cavity, Paranasal Sinuses and Skull Base.

Authors:  Lester D R Thompson; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2022-03-21

4.  Advances in multidisciplinary therapy for meningiomas.

Authors:  Priscilla K Brastianos; Evanthia Galanis; Nicholas Butowski; Jason W Chan; Ian F Dunn; Roland Goldbrunner; Christel Herold-Mende; Franziska M Ippen; Christian Mawrin; Michael W McDermott; Andrew Sloan; James Snyder; Ghazaleh Tabatabai; Marcos Tatagiba; Joerg C Tonn; Patrick Y Wen; Kenneth Aldape; Farshad Nassiri; Gelareh Zadeh; Michael D Jenkinson; David R Raleigh
Journal:  Neuro Oncol       Date:  2019-01-14       Impact factor: 12.300

5.  Pharmacokinetic analysis of [68Ga]Ga-DOTA-TOC PET in meningiomas for assessment of in vivo somatostatin receptor subtype 2.

Authors:  Asma Bashir; Mark Bitsch Vestergaard; Tina Binderup; Helle Broholm; Lisbeth Marner; Morten Ziebell; Kåre Fugleholm; Tiit Mathiesen; Andreas Kjær; Ian Law
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-03-13       Impact factor: 9.236

Review 6.  An overview of meningiomas.

Authors:  Robin A Buerki; Craig M Horbinski; Timothy Kruser; Peleg M Horowitz; Charles David James; Rimas V Lukas
Journal:  Future Oncol       Date:  2018-08-07       Impact factor: 3.404

7.  Comprehensive Molecular Profiling Identifies FOXM1 as a Key Transcription Factor for Meningioma Proliferation.

Authors:  Harish N Vasudevan; Steve E Braunstein; Joanna J Phillips; Melike Pekmezci; Bryan A Tomlin; Ashley Wu; Gerald F Reis; Stephen T Magill; Jie Zhang; Felix Y Feng; Theodore Nicholaides; Susan M Chang; Penny K Sneed; Michael W McDermott; Mitchel S Berger; Arie Perry; David R Raleigh
Journal:  Cell Rep       Date:  2018-03-27       Impact factor: 9.423

8.  Evaluation of Ac-Lys0(IRDye800CW)Tyr3-octreotate as a novel tracer for SSTR2-targeted molecular fluorescence guided surgery in meningioma.

Authors:  Frank A E Kruyt; Rob J M Groen; Bianca M Dijkstra; Marion de Jong; Marcus C M Stroet; Fritz Andreae; Sebastiaan E Dulfer; Marieke Everts; Schelto Kruijff; Julie Nonnekens; Wilfred F A den Dunnen
Journal:  J Neurooncol       Date:  2021-03-26       Impact factor: 4.130

9.  CD13 is a useful tool in the differential diagnosis of meningiomas with potential biological and prognostic implications.

Authors:  Stefano Marletta; Claudio Luchini; Nicola Sperandio; Evelin Torresani; Alessandro Sorio; Ilaria Girolami; Aldo Scarpa; Albino Eccher; Claudio Ghimenton
Journal:  Virchows Arch       Date:  2022-02-25       Impact factor: 4.535

10.  Sarcomatous Meningioma: Diagnostic Pitfalls and the Utility of Molecular Testing.

Authors:  Calixto-Hope G Lucas; Patrick Devine; David A Solomon; Caterina Giannini; Guido Reifenberger; Sonika Dahiya; Dario Caccamo; Arie Perry
Journal:  J Neuropathol Exp Neurol       Date:  2021-09-10       Impact factor: 3.148
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.